ストックスクリーナーアプリを入手
4.55
2.71%
0.12
前日終値:
$4.43
開ける：
$4.48
24時間の取引高:
150.10K
Relative Volume:
0.49
時価総額：
$256.91M
収益：
$2.76M
当期純損益:
$-49.12M
株価収益率:
-3.0333
EPS:
-1.5
ネットキャッシュフロー:
$-46.21M
1週間 パフォーマンス:
+15.48%
1か月 パフォーマンス:
+16.97%
6か月 パフォーマンス:
+66.06%
1年 パフォーマンス:
-16.36%
1日の値動き範囲:
$4.15
$4.55
1週間の範囲:
$3.89
$4.80
52週間の値動き範囲:
$2.20
$6.30
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
名前
Orchestra Biomed Holdings Inc
セクター
電話
646-343-9298
住所
150 UNION SQUARE DRIVE, NEW HOPE
OBIO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
4.55 | 250.14M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.11 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
760.62 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
437.90 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
921.89 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
200.18 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-20 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-03-20 | 開始されました | BTIG Research | Buy |
| 2025-01-02 | 開始されました | Barclays | Overweight |
| 2024-08-22 | 開始されました | H.C. Wainwright | Buy |
| 2024-07-25 | 開始されました | B. Riley Securities | Buy |
| 2024-01-19 | 開始されました | Jefferies | Buy |
| 2023-02-24 | 開始されました | Piper Sandler | Overweight |
| 2023-02-07 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Orchestra Biomed Holdings Inc (OBIO) 最新ニュース
How currency fluctuations impact Orchestra BioMed Holdings Inc. stockDividend Hike & Low Drawdown Trading Strategies - newser.com
Orchestra BioMed’s Big Cash Infusion Sets Stage for High-Stakes Cardiology Trials - MSN
Will Orchestra BioMed Holdings Inc. stock outperform tech sector in 2025July 2025 Snapshot & Entry and Exit Point Strategies - newser.com
Orchestra BioMed Study Shows AVIM Therapy Could Transform Care for Hypertensive Heart Disease - MSN
Exit strategy if you’re trapped in Orchestra BioMed Holdings Inc.July 2025 Selloffs & Weekly Watchlist for Consistent Profits - newser.com
Is Orchestra BioMed Holdings Inc. stock supported by strong cash flowsWeekly Stock Summary & Consistent Profit Trade Alerts - newser.com
How sentiment analysis helps forecast Orchestra BioMed Holdings Inc.2025 Volatility Report & Expert Curated Trade Setups - newser.com
Orchestra BioMed Holdings Director David P Hochman Acquires 5,000 Shares - TradingView
Chmn Hochman Buys 5,000 ($20.4K) Of Orchestra BioMed Holdings Inc [OBIO] - TradingView
[Form 4] Orchestra BioMed Holdings, Inc. Insider Trading Activity - Stock Titan
Is this a good reentry point in Orchestra BioMed Holdings Inc.Day Trade & Free Verified High Yield Trade Plans - newser.com
Research Analysts Offer Predictions for OBIO FY2025 Earnings - Defense World
Barclays Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Overweight Recommendation - MSN
Will Orchestra BioMed Holdings Inc. stock recover after recent drop2025 Year in Review & Real-Time Stock Price Movement Reports - newser.com
Can Orchestra BioMed Holdings Inc. stock withstand economic slowdownJuly 2025 Retail & Safe Swing Trade Setups - newser.com
Chmn Hochman Surrenders 6,566 Of Orchestra BioMed Holdings Inc [OBIO] - TradingView
Views of Wall Street’s Leading Experts on Orchestra BioMed Holdings Inc - Setenews
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Orchestra BioMed Kicks Off Pivotal U.S. Trial of Non-Coated Sirolimus Balloon - MSN
Orchestra BioMed Secures FDA Breakthrough Designation - TipRanks
Orchestra BioMed Holdings, Inc. Provides Significant Business Updates - TradingView
[8-K] Orchestra BioMed Holdings, Inc. Reports Material Event | OBIO SEC FilingForm 8-K - Stock Titan
Orchestra BioMed Holdings Insiders May Regret Not Buying More, Market Cap Hits US$232m - simplywall.st
Can Orchestra BioMed Holdings Inc. stock reach $100 price target - newser.com
Barclays Maintains Orchestra BioMed Holdings (OBIO) Overweight Recommendation - Nasdaq
Barclays Lowers Price Target for OBIO While Maintaining Overweig - GuruFocus
Orchestra BioMed Secures $111M to Advance Late-Stage Cardiac Therapies, Hits Multiple FDA Milestones - MSN
Orchestra BioMed to Deliver Major Business Update Amid Rapid Clinical Momentum - MSN
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - The Manila Times
Orchestra BioMed (NASDAQ: OBIO) to join Jefferies London and Piper; Dec. 3 fireside chat - Stock Titan
What To Expect From Orchestra BioMed Holdings Inc (OBIO) Q3 2025 Earnings - Yahoo Finance
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Beats Revenue Estimates - sharewise.com
Orchestra BioMed Secures Funding And Upgrades Clinical Plans - Finimize
Orchestra BioMed Holdings Q3 Loss Widens - Nasdaq
Orchestra BioMed Q3 revenue beats expectations - MarketScreener
Orchestra BioMed Secures $147.6 Million in Capital and Initiates Patient Enrollment for Virtue Trial - Quiver Quantitative
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates - The Manila Times
Orchestra Biomed Holdings Inc (OBIO) 財務データ
収益
当期純利益
現金流量
EPS
Orchestra Biomed Holdings Inc (OBIO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Aryeh Jason | Director |
Sep 19 '25 |
Buy |
2.45 |
1,000 |
2,450 |
108,482 |
| Fain Eric S | Director |
Aug 25 '25 |
Buy |
2.61 |
5,760 |
15,034 |
71,709 |
| Sherman Darren | See Remarks |
Aug 25 '25 |
Buy |
2.62 |
3,000 |
7,860 |
926,837 |
| Hochman David P | See Remarks |
Aug 21 '25 |
Buy |
2.49 |
6,000 |
14,940 |
651,460 |
| Taylor Andrew Lawrence | Chief Financial Officer |
Aug 25 '25 |
Buy |
2.55 |
2,000 |
5,100 |
482,788 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Aug 01 '25 |
Buy |
2.75 |
700,000 |
1,925,000 |
5,292,556 |
| Hochman David P | See Remarks |
Aug 04 '25 |
Buy |
2.75 |
20,000 |
55,000 |
349,331 |
| Fain Eric S | Director |
Jun 26 '25 |
Sale |
3.05 |
2,683 |
8,183 |
50,949 |
1.64%
0.70%
大文字化:
|
ボリューム (24 時間):